Instagram Story Viewer

1 in 8 women in the U.S. will be diagnosed with breast cancer in their lifetime. We're sparking a conversation to change the odds for women everywhere. Follow along as we continue to share important stats and actionable tips in advance of 1 in 8 Day on Oct 18th.

Join us in spreading the word: Share this post and tag eight loved ones who should see this message.

Comment “NONE” to get involved and receive helpful resources in your inbox. Together, let’s turn 1 in 8 to none in 8.

1 in 8 women in the U.S. will be diagnosed with breast cancer in their lifetime. We're sparking a conversation to change the odds for women everywhere. Follow along as we continue to share important stats and actionable tips in advance of 1 in 8 Day on Oct 18th.

Join us in spreading the word: Share this post and tag eight loved ones who should see this message.

Comment “NONE” to get involved and receive helpful resources in your inbox. Together, let’s turn 1 in 8 to none in 8.

1 in 8 women in the U.S. will be diagnosed with breast cancer in their lifetime. We're sparking a conversation to change the odds for women everywhere. Follow along as we continue to share important stats and actionable tips in advance of 1 in 8 Day on Oct 18th.

Join us in spreading the word: Share this post and tag eight loved ones who should see this message.

Comment “NONE” to get involved and receive helpful resources in your inbox. Together, let’s turn 1 in 8 to none in 8.

1 in 8 women in the U.S. will be diagnosed with breast cancer in their lifetime. We're sparking a conversation to change the odds for women everywhere. Follow along as we continue to share important stats and actionable tips in advance of 1 in 8 Day on Oct 18th.

Join us in spreading the word: Share this post and tag eight loved ones who should see this message.

Comment “NONE” to get involved and receive helpful resources in your inbox. Together, let’s turn 1 in 8 to none in 8.

1 in 8 women in the U.S. will be diagnosed with breast cancer in their lifetime. We're sparking a conversation to change the odds for women everywhere. Follow along as we continue to share important stats and actionable tips in advance of 1 in 8 Day on Oct 18th.

Join us in spreading the word: Share this post and tag eight loved ones who should see this message.

Comment “NONE” to get involved and receive helpful resources in your inbox. Together, let’s turn 1 in 8 to none in 8.

1 in 8 women in the U.S. will be diagnosed with breast cancer in their lifetime. We're sparking a conversation to change the odds for women everywhere. Follow along as we continue to share important stats and actionable tips in advance of 1 in 8 Day on Oct 18th.

Join us in spreading the word: Share this post and tag eight loved ones who should see this message.

Comment “NONE” to get involved and receive helpful resources in your inbox. Together, let’s turn 1 in 8 to none in 8.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Mary-Claire King is a pioneer in breast cancer genetics, best known for discovering the BRCA1 gene—one of the most important breakthroughs in cancer research.

With support from BCRF, her work has transformed how we understand risk, making it possible for women at high risk to take proactive, lifesaving measures. Today, her research continues to uncover new genetic mechanisms—helping ensure that knowledge of our genetics is accessible to all women.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Mary-Claire King is a pioneer in breast cancer genetics, best known for discovering the BRCA1 gene—one of the most important breakthroughs in cancer research.

With support from BCRF, her work has transformed how we understand risk, making it possible for women at high risk to take proactive, lifesaving measures. Today, her research continues to uncover new genetic mechanisms—helping ensure that knowledge of our genetics is accessible to all women.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Mary-Claire King is a pioneer in breast cancer genetics, best known for discovering the BRCA1 gene—one of the most important breakthroughs in cancer research.

With support from BCRF, her work has transformed how we understand risk, making it possible for women at high risk to take proactive, lifesaving measures. Today, her research continues to uncover new genetic mechanisms—helping ensure that knowledge of our genetics is accessible to all women.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Mary-Claire King is a pioneer in breast cancer genetics, best known for discovering the BRCA1 gene—one of the most important breakthroughs in cancer research.

With support from BCRF, her work has transformed how we understand risk, making it possible for women at high risk to take proactive, lifesaving measures. Today, her research continues to uncover new genetic mechanisms—helping ensure that knowledge of our genetics is accessible to all women.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Mary-Claire King is a pioneer in breast cancer genetics, best known for discovering the BRCA1 gene—one of the most important breakthroughs in cancer research.

With support from BCRF, her work has transformed how we understand risk, making it possible for women at high risk to take proactive, lifesaving measures. Today, her research continues to uncover new genetic mechanisms—helping ensure that knowledge of our genetics is accessible to all women.

Real breakthroughs start with real research.

Learn more at BCRF.org.

This Asian American and Pacific Islander (AAPI) Heritage Month, we’re highlighting an urgent and often overlooked trend in breast cancer.

Breast cancer rates in AAPI women have increased nearly 50% since 2000, and AAPI women now represent the largest group of women diagnosed under 40.

These shifts underscore the importance of continued research, early detection, and equitable access to care for all communities.

BCRF is committed to funding research that helps us better understand these disparities—and work toward better outcomes for everyone.

Comment "AAPI" to learn more about how BCRF is advancing research on AAPI breast cancer risk and outcomes.

We had the privilege of visiting the NYC offices of the Breast Cancer Research Foundation, hosted by one of our own Janice Jam producers, Christine Ward 🩷

Spending time with the passionate team behind BCRF was both inspiring and grounding. We heard firsthand how critical research funding drives real progress, fueling breakthroughs in prevention, treatment, and ultimately, a cure for a disease that has touched so many lives.

This is exactly why The Janice Jam is so meaningful. Supporting BCRF means supporting science that saves lives. Research doesn’t just matter, it’s the reason cures become possible.

Thank you to @bcrfcure for your continued partnership over the past three years and for the vital work you do every single day.

See you on May 4th!
#teamjanice🦩

New information—and misinformation—about breast cancer seems to surface every day.

Join us for a live discussion on May 14th at 1pm ET exploring some of the biggest myths, facts, and questions in breast cancer today.

Hear from BCRF researchers Veronica Jones, MD and Evanthia Roussos Torres, MD, PhD, moderated by Sadia Haque Zapp (@sadiahaque_dx2022), as they break down what you really need to know about topics like AI-guided screening, hormone therapy and menopause, DCIS, GLP-1s, and more.

Comment “MYTH” and we’ll DM you the link to sign up for free!

Patient advocacy saves lives.

As we close out National Minority Health Month, BCRF investigator Dr. Sonya Reid highlights how thrivers, survivors, and community partners help underrepresented patients get screened earlier, stay on track with treatment, and navigate care.

Comment “MORE” to learn about breast cancer disparities and what BCRF investigators are doing to close gaps in outcomes.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Suzanne Fuqua is uncovering why some breast cancers stop responding to treatment and begin to spread.

With support from BCRF, her research shows that combining hormone-suppressing therapy with drugs that target DNA may help reduce tumor growth in treatment-resistant cancers—and her team is now working to make these approaches even more effective.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Suzanne Fuqua is uncovering why some breast cancers stop responding to treatment and begin to spread.

With support from BCRF, her research shows that combining hormone-suppressing therapy with drugs that target DNA may help reduce tumor growth in treatment-resistant cancers—and her team is now working to make these approaches even more effective.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Suzanne Fuqua is uncovering why some breast cancers stop responding to treatment and begin to spread.

With support from BCRF, her research shows that combining hormone-suppressing therapy with drugs that target DNA may help reduce tumor growth in treatment-resistant cancers—and her team is now working to make these approaches even more effective.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Suzanne Fuqua is uncovering why some breast cancers stop responding to treatment and begin to spread.

With support from BCRF, her research shows that combining hormone-suppressing therapy with drugs that target DNA may help reduce tumor growth in treatment-resistant cancers—and her team is now working to make these approaches even more effective.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Suzanne Fuqua is uncovering why some breast cancers stop responding to treatment and begin to spread.

With support from BCRF, her research shows that combining hormone-suppressing therapy with drugs that target DNA may help reduce tumor growth in treatment-resistant cancers—and her team is now working to make these approaches even more effective.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Liquid biopsies, or blood tests for cancer detection, are a hot topic in the cancer community. The technology offers significant hope for early detection of a recurrence but right now, a positive test does not change clinical care. Studies support ctDNA as a valuable tool but its use must be standardized and validated before it’s ready to be incorporated into routine care.

At AACR, scientists shared how they are working to improve the accuracy of blood tests and maximize the information it can extract so that it may one day provide clear and actionable data for patients.

Liquid biopsies, or blood tests for cancer detection, are a hot topic in the cancer community. The technology offers significant hope for early detection of a recurrence but right now, a positive test does not change clinical care. Studies support ctDNA as a valuable tool but its use must be standardized and validated before it’s ready to be incorporated into routine care.

At AACR, scientists shared how they are working to improve the accuracy of blood tests and maximize the information it can extract so that it may one day provide clear and actionable data for patients.

Liquid biopsies, or blood tests for cancer detection, are a hot topic in the cancer community. The technology offers significant hope for early detection of a recurrence but right now, a positive test does not change clinical care. Studies support ctDNA as a valuable tool but its use must be standardized and validated before it’s ready to be incorporated into routine care.

At AACR, scientists shared how they are working to improve the accuracy of blood tests and maximize the information it can extract so that it may one day provide clear and actionable data for patients.

Liquid biopsies, or blood tests for cancer detection, are a hot topic in the cancer community. The technology offers significant hope for early detection of a recurrence but right now, a positive test does not change clinical care. Studies support ctDNA as a valuable tool but its use must be standardized and validated before it’s ready to be incorporated into routine care.

At AACR, scientists shared how they are working to improve the accuracy of blood tests and maximize the information it can extract so that it may one day provide clear and actionable data for patients.

Liquid biopsies, or blood tests for cancer detection, are a hot topic in the cancer community. The technology offers significant hope for early detection of a recurrence but right now, a positive test does not change clinical care. Studies support ctDNA as a valuable tool but its use must be standardized and validated before it’s ready to be incorporated into routine care.

At AACR, scientists shared how they are working to improve the accuracy of blood tests and maximize the information it can extract so that it may one day provide clear and actionable data for patients.

Liquid biopsies, or blood tests for cancer detection, are a hot topic in the cancer community. The technology offers significant hope for early detection of a recurrence but right now, a positive test does not change clinical care. Studies support ctDNA as a valuable tool but its use must be standardized and validated before it’s ready to be incorporated into routine care.

At AACR, scientists shared how they are working to improve the accuracy of blood tests and maximize the information it can extract so that it may one day provide clear and actionable data for patients.

Liquid biopsies, or blood tests for cancer detection, are a hot topic in the cancer community. The technology offers significant hope for early detection of a recurrence but right now, a positive test does not change clinical care. Studies support ctDNA as a valuable tool but its use must be standardized and validated before it’s ready to be incorporated into routine care.

At AACR, scientists shared how they are working to improve the accuracy of blood tests and maximize the information it can extract so that it may one day provide clear and actionable data for patients.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Charles Perou helped redefine breast cancer—showing that it is not one disease, but at least four distinct subtypes, each requiring its own treatment approach.

With support from BCRF, his work uncovered how the unique biology of each tumor drives its growth—paving the way for more personalized, effective care. Next, his team is studying how certain genes help tumors evade the immune system, opening new paths for treatment.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Charles Perou helped redefine breast cancer—showing that it is not one disease, but at least four distinct subtypes, each requiring its own treatment approach.

With support from BCRF, his work uncovered how the unique biology of each tumor drives its growth—paving the way for more personalized, effective care. Next, his team is studying how certain genes help tumors evade the immune system, opening new paths for treatment.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Charles Perou helped redefine breast cancer—showing that it is not one disease, but at least four distinct subtypes, each requiring its own treatment approach.

With support from BCRF, his work uncovered how the unique biology of each tumor drives its growth—paving the way for more personalized, effective care. Next, his team is studying how certain genes help tumors evade the immune system, opening new paths for treatment.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Charles Perou helped redefine breast cancer—showing that it is not one disease, but at least four distinct subtypes, each requiring its own treatment approach.

With support from BCRF, his work uncovered how the unique biology of each tumor drives its growth—paving the way for more personalized, effective care. Next, his team is studying how certain genes help tumors evade the immune system, opening new paths for treatment.

Real breakthroughs start with real research.

Learn more at BCRF.org.

Doing your own research can be powerful when backed by trusted experts and evidence-based science. That’s why we’re sharing the stories of BCRF-funded scientists—the world’s leading breast cancer researchers.

Dr. Charles Perou helped redefine breast cancer—showing that it is not one disease, but at least four distinct subtypes, each requiring its own treatment approach.

With support from BCRF, his work uncovered how the unique biology of each tumor drives its growth—paving the way for more personalized, effective care. Next, his team is studying how certain genes help tumors evade the immune system, opening new paths for treatment.

Real breakthroughs start with real research.

Learn more at BCRF.org.

We met with BCRF investigator Dr. Virginia Borges to break down what the science actually shows about common misconceptions surrounding breast cancer in younger women—and what current evidence does (and doesn’t) support.

BCRF-funded research helps turn questions and confusion into clarity, empowering patients to make informed decisions about their health.

BCRF researcher Dr. Pepper Schedin presented the underlying biology behind postpartum breast cancer (PPBC)—a type that is on the rise as breast cancer incidence in younger women continue to increase. Dr. Schedin reveals why childbirth can trigger breast cancer within a decade of giving birth and why it's important for PPBC patients to stay on treatment.

BCRF researcher Dr. Pepper Schedin presented the underlying biology behind postpartum breast cancer (PPBC)—a type that is on the rise as breast cancer incidence in younger women continue to increase. Dr. Schedin reveals why childbirth can trigger breast cancer within a decade of giving birth and why it's important for PPBC patients to stay on treatment.

BCRF researcher Dr. Pepper Schedin presented the underlying biology behind postpartum breast cancer (PPBC)—a type that is on the rise as breast cancer incidence in younger women continue to increase. Dr. Schedin reveals why childbirth can trigger breast cancer within a decade of giving birth and why it's important for PPBC patients to stay on treatment.

BCRF researcher Dr. Pepper Schedin presented the underlying biology behind postpartum breast cancer (PPBC)—a type that is on the rise as breast cancer incidence in younger women continue to increase. Dr. Schedin reveals why childbirth can trigger breast cancer within a decade of giving birth and why it's important for PPBC patients to stay on treatment.

BCRF researcher Dr. Pepper Schedin presented the underlying biology behind postpartum breast cancer (PPBC)—a type that is on the rise as breast cancer incidence in younger women continue to increase. Dr. Schedin reveals why childbirth can trigger breast cancer within a decade of giving birth and why it's important for PPBC patients to stay on treatment.

BCRF researcher Dr. Pepper Schedin presented the underlying biology behind postpartum breast cancer (PPBC)—a type that is on the rise as breast cancer incidence in younger women continue to increase. Dr. Schedin reveals why childbirth can trigger breast cancer within a decade of giving birth and why it's important for PPBC patients to stay on treatment.

Breast cancer treatment can raise important questions about fertility.

While the disease itself doesn’t affect fertility, treatments like chemotherapy and hormone therapy can impact reproductive health—making early conversations about options essential.

The encouraging news: fertility preservation is possible, and research continues to expand what’s safe and achievable for patients and survivors.

This National Infertility Awareness Week, we’re highlighting what every patient deserves to know: fertility should be part of the care conversation from the start. Comment "FERTILITY" to learn more.

Breast cancer treatment can raise important questions about fertility.

While the disease itself doesn’t affect fertility, treatments like chemotherapy and hormone therapy can impact reproductive health—making early conversations about options essential.

The encouraging news: fertility preservation is possible, and research continues to expand what’s safe and achievable for patients and survivors.

This National Infertility Awareness Week, we’re highlighting what every patient deserves to know: fertility should be part of the care conversation from the start. Comment "FERTILITY" to learn more.

Breast cancer treatment can raise important questions about fertility.

While the disease itself doesn’t affect fertility, treatments like chemotherapy and hormone therapy can impact reproductive health—making early conversations about options essential.

The encouraging news: fertility preservation is possible, and research continues to expand what’s safe and achievable for patients and survivors.

This National Infertility Awareness Week, we’re highlighting what every patient deserves to know: fertility should be part of the care conversation from the start. Comment "FERTILITY" to learn more.

Breast cancer treatment can raise important questions about fertility.

While the disease itself doesn’t affect fertility, treatments like chemotherapy and hormone therapy can impact reproductive health—making early conversations about options essential.

The encouraging news: fertility preservation is possible, and research continues to expand what’s safe and achievable for patients and survivors.

This National Infertility Awareness Week, we’re highlighting what every patient deserves to know: fertility should be part of the care conversation from the start. Comment "FERTILITY" to learn more.

Breast cancer treatment can raise important questions about fertility.

While the disease itself doesn’t affect fertility, treatments like chemotherapy and hormone therapy can impact reproductive health—making early conversations about options essential.

The encouraging news: fertility preservation is possible, and research continues to expand what’s safe and achievable for patients and survivors.

This National Infertility Awareness Week, we’re highlighting what every patient deserves to know: fertility should be part of the care conversation from the start. Comment "FERTILITY" to learn more.